303 related articles for article (PubMed ID: 30374128)
1. Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity.
Knier B; Hiltensperger M; Sie C; Aly L; Lepennetier G; Engleitner T; Garg G; Muschaweckh A; Mitsdörffer M; Koedel U; Höchst B; Knolle P; Gunzer M; Hemmer B; Rad R; Merkler D; Korn T
Nat Immunol; 2018 Dec; 19(12):1341-1351. PubMed ID: 30374128
[TBL] [Abstract][Full Text] [Related]
2. Frontline Science: Induction of experimental autoimmune encephalomyelitis mobilizes Th17-promoting myeloid derived suppressor cells to the lung.
Glenn JD; Liu C; Whartenby KA
J Leukoc Biol; 2019 May; 105(5):829-841. PubMed ID: 30762897
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-derived suppressor cells mediate tolerance induction in autoimmune disease.
Wegner A; Verhagen J; Wraith DC
Immunology; 2017 May; 151(1):26-42. PubMed ID: 28140447
[TBL] [Abstract][Full Text] [Related]
4. Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.
Parekh VV; Wu L; Olivares-Villagómez D; Wilson KT; Van Kaer L
J Immunol; 2013 Mar; 190(5):1948-60. PubMed ID: 23345328
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.
Elliott DM; Singh N; Nagarkatti M; Nagarkatti PS
Front Immunol; 2018; 9():1782. PubMed ID: 30123217
[TBL] [Abstract][Full Text] [Related]
6. The Role of Myeloid-Derived Suppressor Cells in Multiple Sclerosis and Its Animal Model.
Jiang Q; Duan J; Van Kaer L; Yang G
Aging Dis; 2024 May; 15(3):1329-1343. PubMed ID: 37307825
[TBL] [Abstract][Full Text] [Related]
7. Targeting the GM-CSF receptor for the treatment of CNS autoimmunity.
Ifergan I; Davidson TS; Kebir H; Xu D; Palacios-Macapagal D; Cann J; Rodgers JM; Hunter ZN; Pittet CL; Beddow S; Jones CA; Prat A; Sleeman MA; Miller SD
J Autoimmun; 2017 Nov; 84():1-11. PubMed ID: 28641926
[TBL] [Abstract][Full Text] [Related]
8. Remote control of T
Vijitha N; Engel DR
J Leukoc Biol; 2019 May; 105(5):827-828. PubMed ID: 30958568
[TBL] [Abstract][Full Text] [Related]
9. Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
Cantoni C; Cignarella F; Ghezzi L; Mikesell B; Bollman B; Berrien-Elliott MM; Ireland AR; Fehniger TA; Wu GF; Piccio L
Acta Neuropathol; 2017 Jan; 133(1):61-77. PubMed ID: 27704281
[TBL] [Abstract][Full Text] [Related]
10. Pseudolycorine chloride ameliorates Th17 cell-mediated central nervous system autoimmunity by restraining myeloid-derived suppressor cell expansion.
Zhang G; Zhu X; Yang F; Li J; Leng X; Mo C; Li L; Wang Y
Pharm Biol; 2022 Dec; 60(1):899-908. PubMed ID: 36082828
[TBL] [Abstract][Full Text] [Related]
11. Myeloid derived suppressor cells in inflammatory conditions of the central nervous system.
Melero-Jerez C; Ortega MC; Moliné-Velázquez V; Clemente D
Biochim Biophys Acta; 2016 Mar; 1862(3):368-80. PubMed ID: 26527182
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system infiltrates are characterized by features of ongoing B cell-related immune activity in MP4-induced experimental autoimmune encephalomyelitis.
Batoulis H; Wunsch M; Birkenheier J; Rottlaender A; Gorboulev V; Kuerten S
Clin Immunol; 2015 May; 158(1):47-58. PubMed ID: 25796192
[TBL] [Abstract][Full Text] [Related]
13. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.
Prinz M; Schmidt H; Mildner A; Knobeloch KP; Hanisch UK; Raasch J; Merkler D; Detje C; Gutcher I; Mages J; Lang R; Martin R; Gold R; Becher B; Brück W; Kalinke U
Immunity; 2008 May; 28(5):675-86. PubMed ID: 18424188
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis.
Casacuberta-Serra S; Costa C; Eixarch H; Mansilla MJ; López-Estévez S; Martorell L; Parés M; Montalban X; Espejo C; Barquinero J
Exp Neurol; 2016 Dec; 286():50-60. PubMed ID: 27693617
[TBL] [Abstract][Full Text] [Related]
15. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
[TBL] [Abstract][Full Text] [Related]
16. TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs.
Won H; Moreira D; Gao C; Duttagupta P; Zhao X; Manuel E; Diamond D; Yuan YC; Liu Z; Jones J; D'Apuzzo M; Pal S; Kortylewski M
J Leukoc Biol; 2017 Aug; 102(2):423-436. PubMed ID: 28533357
[TBL] [Abstract][Full Text] [Related]
17. The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies.
Racke MK
Curr Opin Neurol; 2008 Apr; 21 Suppl 1():S9-S18. PubMed ID: 18388801
[TBL] [Abstract][Full Text] [Related]
18. T cell mediated pathogenesis in EAE: Molecular mechanisms.
Kurschus FC
Biomed J; 2015; 38(3):183-93. PubMed ID: 25900928
[TBL] [Abstract][Full Text] [Related]
19. CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation.
Hwang D; Seyedsadr MS; Ishikawa LLW; Boehm A; Sahin Z; Casella G; Jang S; Gonzalez MV; Garifallou JP; Hakonarson H; Zhang W; Xiao D; Rostami A; Zhang GX; Ciric B
Proc Natl Acad Sci U S A; 2022 Apr; 119(14):e2111804119. PubMed ID: 35353625
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF Promotes Chronic Disability in Experimental Autoimmune Encephalomyelitis by Altering the Composition of Central Nervous System-Infiltrating Cells, but Is Dispensable for Disease Induction.
Duncker PC; Stoolman JS; Huber AK; Segal BM
J Immunol; 2018 Feb; 200(3):966-973. PubMed ID: 29288202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
